Grifols, S.A. - 14 Year Stock Price History | GRFS

Historical daily share price chart and data for Grifols, S.A. since 2011 adjusted for splits and dividends. The latest closing stock price for Grifols, S.A. as of February 21, 2025 is 7.45.
  • The all-time high Grifols, S.A. stock closing price was 24.64 on February 21, 2020.
  • The Grifols, S.A. 52-week high stock price is 9.96, which is 33.7% above the current share price.
  • The Grifols, S.A. 52-week low stock price is 5.30, which is 28.9% below the current share price.
  • The average Grifols, S.A. stock price for the last 52 weeks is 7.63.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Grifols, S.A. Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 7.2724 7.5400 7.8600 6.6200 7.4500 0.13%
2024 7.8150 11.0500 11.3800 5.4700 7.4400 -35.64%
2023 9.0062 8.7400 11.5600 6.6500 11.5600 36.00%
2022 9.8832 11.6400 13.2800 5.9500 8.5000 -24.31%
2021 15.4296 18.4474 19.2554 10.2100 11.2300 -37.44%
2020 18.8699 22.6921 24.6440 14.8076 17.9510 -19.84%
2019 19.2945 16.9128 22.6152 16.4909 22.3940 30.10%
2018 19.7430 21.4428 22.8735 16.3502 17.2128 -18.05%
2017 18.4119 14.5010 21.6838 14.5010 21.0029 45.11%
2016 13.8857 14.0710 15.3799 12.5036 14.4739 1.47%
2015 14.2353 14.8176 15.4842 12.8339 14.2647 -2.49%
2014 16.4741 14.8345 19.8092 12.6985 14.6283 -4.42%
2013 12.5210 10.7511 15.3515 10.2645 15.3049 40.71%
2012 7.6290 4.4104 10.8769 4.2986 10.8769 146.17%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $5.122B $7.134B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) JP $83.888B 33.10
Zoetis Inc. (ZTS) US $71.853B 27.10
Takeda Pharmaceutical Co. (TAK) JP $44.737B 9.90
Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) JP $43.224B 26.34
Sandoz Group AG Sponsored ADR (SDZNY) CH $20.442B 0.00
Merck KGaA (MKKGY) DE $18.230B 16.33
Astellas Pharma Inc. (ALPMY) JP $17.608B 12.47
Summit Therapeutics PLC (SMMT) US $16.312B 0.00
United Therapeutics Corporation (UTHR) US $16.121B 15.86
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) JP $12.709B 0.00
Neurocrine Biosciences, Inc. (NBIX) US $12.033B 36.68
Orion OYJ Unsponsored ADR (ORINY) FI $7.681B 21.59
Madrigal Pharmaceuticals, Inc. (MDGL) US $7.333B 0.00
Corcept Therapeutics Incorporated (CORT) US $6.657B 50.43
Stevanato Group S.p.A. (STVN) IT $6.329B 40.98
Hikma Pharmaceuticals Plc (HKMPF) GB $6.245B 0.00
Ionis Pharmaceuticals, Inc. (IONS) US $5.138B 0.00
Ono Pharmaceutical Co. (OPHLF) JP $4.650B 9.52
Recursion Pharmaceuticals, Inc. (RXRX) US $3.626B 0.00
Crinetics Pharmaceuticals, Inc. (CRNX) US $3.474B 0.00
Catalyst Pharmaceuticals, Inc. (CPRX) US $2.579B 11.69
AMNEAL PHARMACEUTICALS, INC. (AMRX) US $2.426B 14.50
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) GB $2.193B 0.00
Hypermarcas (HYPMY) BR $2.154B 0.00
Soleno Therapeutics, Inc. (SLNO) US $1.989B 0.00
BioCryst Pharmaceuticals, Inc. (BCRX) US $1.908B 0.00
NewAmsterdam Pharma Company N.V. (NAMS) NL $1.716B 0.00
Evotec AG (EVO) DE $1.573B 0.00
Dyne Therapeutics, Inc. (DYN) US $1.426B 0.00
Guardian Pharmacy Services, Inc. (GRDN) US $1.239B 0.00
Ardelyx, Inc. (ARDX) US $1.198B 0.00
Indivior PLC (INDV) US $1.165B 5.06
Aurinia Pharmaceuticals Inc (AUPH) CA $1.135B 0.00
Xencor, Inc. (XNCR) US $1.102B 0.00
Ocular Therapeutix, Inc. (OCUL) US $1.101B 0.00
ARS Pharmaceuticals, Inc. (SPRY) US $1.092B 0.00
Enliven Therapeutics, Inc. (ELVN) US $1.065B 0.00
Harrow, Inc. (HROW) US $1.031B 0.00
Collegium Pharmaceutical, Inc. (COLL) US $0.939B 5.13
Bioventus Inc. (BVS) US $0.812B 25.67
Avadel Pharmaceuticals PLC. (AVDL) IE $0.810B 0.00
Cronos Group Inc. (CRON) CA $0.754B 0.00
Relay Therapeutics, Inc. (RLAY) US $0.656B 0.00
Verve Therapeutics, Inc. (VERV) US $0.616B 0.00
USANA Health Sciences, Inc. (USNA) US $0.606B 11.23
Xeris Biopharma Holdings, Inc. (XERS) US $0.559B 0.00
Elite Pharmaceuticals Inc. (ELTP) US $0.521B 0.00
OmniAb, Inc. (OABI) US $0.515B 0.00
KalVista Pharmaceuticals, Inc. (KALV) US $0.496B 0.00
Savara Inc. (SVRA) US $0.462B 0.00
Theravance Biopharma, Inc. (TBPH) KY $0.458B 0.00
Altimmune, Inc. (ALT) US $0.457B 0.00
ProKidney Corp. (PROK) US $0.437B 0.00
Siga Technologies Inc. (SIGA) US $0.422B 4.92
Zevra Therapeutics, Inc. (ZVRA) US $0.410B 0.00
Organogenesis (ORGO) US $0.404B 0.00
Aldeyra Therapeutics, Inc. (ALDX) US $0.398B 0.00
Akebia Therapeutics, Inc. (AKBA) US $0.393B 0.00
Oruka Therapeutics, Inc. (ORKA) US $0.386B 0.00
CytoDyn Inc. (CYDY) US $0.368B 0.00
Esperion Therapeutics, Inc. (ESPR) US $0.359B 0.00
Rigel Pharmaceuticals, Inc. (RIGL) US $0.354B 143.50
Tourmaline Bio, Inc. (TRML) US $0.313B 0.00
Ironwood Pharmaceuticals, Inc. (IRWD) US $0.290B 0.00
Aquestive Therapeutics, Inc. (AQST) US $0.274B 0.00
Heron Therapeutics, Inc. (HRTX) US $0.263B 0.00
Avita Medical Inc. (RCEL) US $0.256B 0.00
Nature's Sunshine Products, Inc. (NATR) US $0.252B 14.98
Korro Bio, Inc. (KRRO) US $0.246B 0.00
Innate Pharma SA (IPHYF) FR $0.243B 0.00
Amylyx Pharmaceuticals, Inc. (AMLX) US $0.226B 0.00
Profound Medical (PROF) CA $0.225B 0.00
4D Molecular Therapeutics, Inc. (FDMT) US $0.215B 0.00
Inhibikase Therapeutics, Inc. (IKT) US $0.206B 0.00
Lyell Immunopharma, Inc. (LYEL) US $0.205B 0.00
Larimar Therapeutics, Inc. (LRMR) US $0.204B 0.00
MediWound Ltd. (MDWD) IL $0.191B 0.00
Nanobiotix S.A. Sponsored ADR (NBTX) FR $0.177B 0.00
Acrivon Therapeutics, Inc. (ACRV) US $0.172B 0.00
Nektar Therapeutics (NKTR) US $0.172B 0.00
Enanta Pharmaceuticals, Inc. (ENTA) US $0.171B 0.00
VAXART, INC. (VXRT) US $0.162B 0.00
Aclaris Therapeutics, Inc. (ACRS) US $0.160B 0.00
Silence Therapeutics PLC Sponsored ADR (SLN) GB $0.143B 0.00
Champions Oncology, Inc. (CSBR) US $0.141B 0.00
Inotiv, Inc. (NOTV) US $0.137B 0.00
Lexeo Therapeutics, Inc. (LXEO) US $0.129B 0.00
Procaps Group, S.A. (PROCF) LU $0.126B 0.00
Cassava Sciences, Inc. (SAVA) US $0.123B 0.00
electroCore, Inc. (ECOR) US $0.118B 0.00
Telomir Pharmaceuticals, Inc. (TELO) US $0.116B 0.00
Achieve Life Sciences, Inc. (ACHV) CA $0.109B 0.00
Journey Medical Corporation (DERM) US $0.108B 0.00
Corbus Pharmaceuticals Holdings, Inc. (CRBP) US $0.100B 0.00
Cardiol Therapeutics Inc. (CRDL) CA $0.099B 0.00
Galectin Therapeutics Inc. (GALT) US $0.094B 0.00
Arch Biopartners Inc. (ACHFF) CA $0.089B 0.00
Metagenomi, Inc. (MGX) US $0.088B 0.00
Avalo Therapeutics, Inc. (AVTX) US $0.088B 0.00
Regulus Therapeutics Inc. (RGLS) US $0.086B 0.00
Nutriband Inc. (NTRB) US $0.083B 0.00
Assertio Holdings, Inc. (ASRT) US $0.078B 20.32
Protara Therapeutics, Inc. (TARA) US $0.077B 0.00
ESSA Pharma Inc. (EPIX) CA $0.076B 0.00
Pyxis Oncology, Inc. (PYXS) US $0.076B 0.00
Karyopharm Therapeutics Inc. (KPTI) US $0.076B 0.00
Cumberland Pharmaceuticals Inc. (CPIX) US $0.075B 0.00
PMV Pharmaceuticals, Inc. (PMVP) US $0.073B 0.00
FibroGen, Inc (FGEN) US $0.071B 0.00
Mural Oncology PLC (MURA) IE $0.069B 0.00
Fractyl Health, Inc. (GUTS) US $0.068B 0.00
Vivani Medical, Inc. (VANI) US $0.068B 0.00
Unicycive Therapeutics, Inc. (UNCY) US $0.064B 0.00
Century Therapeutics, Inc. (IPSC) US $0.062B 0.00
AleAnna Inc. (ANNA) US $0.062B 0.00
Context Therapeutics Inc. (CNTX) US $0.061B 0.00
Gain Therapeutics, Inc. (GANX) US $0.060B 0.00
OptiNose, Inc. (OPTN) US $0.058B 0.00
Reviva Pharmaceuticals Holdings, Inc. (RVPH) US $0.053B 0.00
Dominari Holdings Inc. (DOMH) US $0.052B 0.00
Iterum Therapeutics PLC (ITRM) IE $0.052B 0.00
Rafael Holdings, Inc. (RFL) US $0.050B 0.00
AlloVir, Inc. (ALVR) US $0.049B 0.00
Prelude Therapeutics Incorporated (PRLD) US $0.048B 0.00
SCYNEXIS, Inc. (SCYX) US $0.041B 0.00
VYNE Therapeutics Inc. (VYNE) US $0.040B 0.00
NRx Pharmaceuticals, Inc. (NRXP) US $0.039B 0.00
CASI Pharmaceuticals Inc. (CASI) CN $0.038B 0.00
Tempest Therapeutics, Inc. (TPST) US $0.038B 0.00
Surrozen, Inc. (SRZN) US $0.036B 0.00
Verrica Pharmaceuticals Inc. (VRCA) US $0.034B 0.00
PolyPid Ltd. (PYPD) IL $0.030B 0.00
Incannex Healthcare Inc. (IXHL) AU $0.029B 0.00
Jupiter Neurosciences, Inc. (JUNS) US $0.028B 0.00
BioVie Inc. (BIVI) US $0.027B 0.00
Natural Alternatives International, Inc. (NAII) US $0.025B 0.00
DURECT Corporation (DRRX) US $0.025B 0.00
Scienture Holdings, Inc. (SCNX) US $0.024B 0.00
Enlivex Therapeutics Ltd. (ENLV) IL $0.021B 0.00
Mannatech, Incorporated (MTEX) US $0.021B 0.00
GlycoMimetics, Inc. (GLYC) US $0.019B 0.00
Carisma Therapeutics Inc. (CARM) US $0.019B 0.00
Vivos Therapeutics, Inc. (VVOS) US $0.018B 0.00
Lipocine Inc. (LPCN) US $0.018B 0.00
MEI Pharma, Inc. (MEIP) US $0.017B 0.00
Tonix Pharmaceuticals Holding Corp. (TNXP) US $0.017B 0.00
MARKER THERAPEUTICS, INC. (MRKR) US $0.017B 0.00
Traws Pharma, Inc. (TRAW) US $0.016B 0.00
Citius Pharmaceuticals, Inc. (CTXR) US $0.015B 0.00
Biomerica, Inc. (BMRA) US $0.015B 0.00
TherapeuticsMD, Inc. (TXMD) US $0.015B 0.00
Cosmos Health Inc. (COSM) US $0.014B 0.00
Lyra Therapeutics, Inc. (LYRA) US $0.013B 0.00
ProPhase Labs, Inc. (PRPH) US $0.013B 0.00
Minerva Neurosciences, Inc (NERV) US $0.013B 0.00
Nuvilex Inc. (PMCB) US $0.012B 0.00
BioLineRx Ltd. (BLRX) IL $0.012B 0.00
Phio Pharmaceuticals Corp. (PHIO) US $0.012B 0.00
Indaptus Therapeutics, Inc. (INDP) US $0.011B 0.00
Mangoceuticals, Inc. (MGRX) US $0.011B 0.00
Kiora Pharmaceuticals, Inc. (KPRX) US $0.010B 0.00
Klotho Neurosciences, Inc. (KLTO) US $0.010B 0.00
Talphera, Inc. (TLPH) US $0.010B 0.00
Jaguar Animal Health, Inc. (JAGX) US $0.010B 0.00
Relmada Therapeutics, Inc. (RLMD) US $0.009B 0.00
Ainos, Inc. (AIMD) US $0.009B 0.00
Addex Therapeutics Ltd. Sponsored ADR (ADXN) CH $0.008B 0.00
XTL Biopharmaceuticals Ltd. (XTLB) IL $0.008B 0.00
Plus Therapeutics, Inc. (PSTV) US $0.007B 0.00
NLS Pharmaceutics Ltd. (NLSP) CH $0.007B 0.00
Xenetic Biosciences, Inc. (XBIO) US $0.006B 0.00
Redhill Biopharma Ltd. (RDHL) IL $0.006B 0.00
Aptorum Group Limited (APM) GB $0.006B 0.00
TransCode Therapeutics Inc. (RNAZ) US $0.006B 0.00
Clearmind Medicine Inc. (CMND) CA $0.006B 0.00
CERo Therapeutics Holdings, Inc. (CERO) US $0.005B 0.00
SciSparc Ltd. (SPRC) IL $0.005B 0.00
Conduit Pharmaceuticals Inc. (CDT) US $0.004B 0.00
Sonoma Pharmaceuticals, Inc. (SNOA) US $0.004B 0.00
InMed Pharmaceuticals Inc. (INM) CA $0.004B 0.00
60 Degrees Pharmaceuticals Inc. (SXTP) US $0.003B 0.00
XORTX Therapeutics Inc. (XRTX) CA $0.003B 0.00
Avenue Therapeutics, Inc. (ATXI) US $0.003B 0.07
Alaunos Therapeutics, Inc. (TCRT) US $0.003B 0.00
Qualigen Therapeutics, Inc. (QLGN) US $0.003B 0.00
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) US $0.003B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals, Inc. (SLRX) US $0.002B 0.00
Galmed Pharmaceuticals Ltd. (GLMD) IL $0.002B 0.00
Heatwurx Inc. (PCSA) US $0.002B 0.00
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) US $0.002B 0.00
Petros Pharmaceuticals, Inc. (PTPI) US $0.001B 0.00
China SXT Pharmaceuticals, Inc. (SXTC) CN $0.001B 0.00
TNF Pharmaceuticals, Inc. (TNFA) US $0.001B 0.00
Aditxt Inc. (ADTX) US $0.001B 0.00
PainReform Ltd. (PRFX) IL $0.000B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
4D pharma PLC Sponsored ADR (LBPS) GB $0.000B 0.00
Patheon N.V. (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals PLC (RVLP) US $0.000B 0.00